MedPath

Serratus anterior plane block for pain relief in breast surgeries

Not yet recruiting
Conditions
Malignant neoplasm of breast,
Registration Number
CTRI/2019/01/017194
Lead Sponsor
SRM medical college hospital and research centre
Brief Summary

44 ASA 1&2 patients posted for modified radical mastectomy surgeries are randomly divided into two groups - group A patients receive ultrasound guided Serratus Anterior Plane block under General anaesthesia with 20 ml of 0.25%ropivacaine  with 8mg Dexamethasone and group B patients receive general anaesthesia without any block. Postoperatively all patients will be administered PCA morphine pump  with basal infusion rate of 0.1mg/hr and bolus of 1mg with lockout interval of 10min. The time to request for first dose of analgesia and the total morphine consumed in 24hours are noted and compared. The side effects, if any are also observed. The hypothesis of the study is by performing Serratus Anterior Plane block, the duration of postoperative analgesia is prolonged and morphine consumption in the postoperative period is decreased.

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
Female
Target Recruitment
44
Inclusion Criteria

ASA 1&2 patients posted for MRM surgeries 60-100kg age 18-60 years.

Exclusion Criteria

ASA 3 and above Patients not willing for the study Allergy to local anaesthetics Coagulation abnormalities.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
duration of postoperative analgesiafrom the administration of block to onset of pain requiring analgesia
Secondary Outcome Measures
NameTimeMethod
analgesic consumption in the postoperative periodfrom the surgery end to 24hours postoperatively

Trial Locations

Locations (1)

SRM medical college hospital

🇮🇳

Kancheepuram, TAMIL NADU, India

SRM medical college hospital
🇮🇳Kancheepuram, TAMIL NADU, India
saravanan
Principal investigator
9884001153
drcrsaravanan@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.